(GNW) Genworth Financial - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US37247D1063

GNW: Mortgage Insurance, Long-Term Care Insurance, Life Insurance, Annuities

Genworth Financial Inc. (NYSE:GNW) is a well-established player in the insurance industry, with a history dating back to 1871. Originally part of GE, it spun off in 2004 and is now headquartered in Richmond, Virginia. The company operates through three core segments: Enact, Long-Term Care Insurance, and Life and Annuities.

The Enact segment specializes in mortgage insurance, offering both private mortgage insurance for residential loans and pool insurance products. This segment is crucial as it provides coverage for prime-based, individually underwritten mortgages, mitigating risks for lenders.

The Long-Term Care Insurance segment addresses the growing need for coverage against escalating long-term care costs. This includes services provided in homes, assisted living facilities, and nursing homes. Despite its importance, this segment faces challenges due to high-risk exposure and actuarial complexities.

The Life and Annuities segment offers a range of products aimed at protection and retirement income. This includes various life insurance policies and fixed and variable annuities, providing customers with diverse financial protection options.

Genworth distributes its products through a mix of direct sales, in-house representatives, and digital marketing. Their approach ensures a broad reach and adaptability to market needs.

Financially, Genworth has a market cap of approximately $3.16 billion. Key metrics include a P/E ratio of 28.38, a P/B ratio of 0.38, and a P/S ratio of 0.43, indicating its current market valuation.

As an investor, understanding Genworths position in the insurance market, especially with an aging population, is key. Their focus on long-term care and mortgage insurance aligns with demographic trends, though the long-term care segments risks warrant careful consideration. Visit their website at https://www.genworth.com for more details.

Additional Sources for GNW Stock

GNW Stock Overview

Market Cap in USD 2,791m
Sector Financial Services
Industry Insurance - Life
GiC Sub-Industry Life & Health Insurance
IPO / Inception 2004-05-25

GNW Stock Ratings

Growth 5y 60.3%
Fundamental -24.4%
Dividend 5.71%
Rel. Strength Industry -17.1
Analysts 3/5
Fair Price Momentum 5.68 USD
Fair Price DCF 7.89 USD

GNW Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y 0.00%
Payout Consistency 19.0%

GNW Growth Ratios

Growth Correlation 3m -52.5%
Growth Correlation 12m 82.2%
Growth Correlation 5y 90.2%
CAGR 5y 8.85%
CAGR/Max DD 5y 0.15
Sharpe Ratio 12m 0.33
Alpha -8.57
Beta 0.92
Volatility 52.87%
Current Volume 5023.1k
Average Volume 20d 4788.1k
What is the price of GNW stocks?
As of February 23, 2025, the stock is trading at USD 6.53 with a total of 5,023,119 shares traded.
Over the past week, the price has changed by -10.43%, over one month by -6.58%, over three months by -14.30% and over the past year by +7.76%.
Is Genworth Financial a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Genworth Financial is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -24.36 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GNW as of February 2025 is 5.68. This means that GNW is currently overvalued and has a potential downside of -13.02%.
Is GNW a buy, sell or hold?
Genworth Financial has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold GNW.
  • Strong Buy: 0
  • Buy: 0
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecast for GNW stock price target?
According to ValueRays Forecast Model, GNW Genworth Financial will be worth about 6.5 in February 2026. The stock is currently trading at 6.53. This means that the stock has a potential upside of +0%.
Issuer Forecast Upside
Wallstreet Target Price 8.5 30.2%
Analysts Target Price 8.5 30.2%
ValueRay Target Price 6.5 0%